申请人:Henderson Andrew Scott
公开号:US20050038248A1
公开(公告)日:2005-02-17
The invention provides 1,2-substituted cyclic compounds useful for treatment of diseases or disorders arising from abnormal or inappropriate cell proliferation, such as tumour growth, tumour metastasis and associated angiogenesis, as well as pharmaceutical compositions comprising these compounds and their use in methods of treatment.
该发明提供了1,2-取代环状化合物,可用于治疗由异常或不适当的细胞增殖引起的疾病或障碍,例如肿瘤生长、肿瘤转移和相关的血管生成,以及包含这些化合物的药物组合物和它们在治疗方法中的应用。